Abiopharma

🔍 CULP H LAWRENCE JR (Director)

Company: GE HealthCare Technologies Inc. (GEHC)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 80,805 shares of Common Stock, par value $0.01 per share at $61.8783 per share (Direct)
  Date: 2026-05-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 151,207.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-05-06 | Code: H | shares_owned_after: 12,699.00 | Footnotes: F2
• Holds 0 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: By family trusts | shares_owned_after: 328,268.00 | Footnotes: F2

Footnotes:

• F1: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
• F2: Reflects the transfer by the reporting person of 37,091 shares of GE HealthCare common stock to a family trust on May 1, 2025.